Attenuation of allergic contact dermatitis through the endocannabinoid system
- PMID: 17556587
- DOI: 10.1126/science.1142265
Attenuation of allergic contact dermatitis through the endocannabinoid system
Abstract
Allergic contact dermatitis affects about 5% of men and 11% of women in industrialized countries and is one of the leading causes for occupational diseases. In an animal model for cutaneous contact hypersensitivity, we show that mice lacking both known cannabinoid receptors display exacerbated allergic inflammation. In contrast, fatty acid amide hydrolase-deficient mice, which have increased levels of the endocannabinoid anandamide, displayed reduced allergic responses in the skin. Cannabinoid receptor antagonists exacerbated allergic inflammation, whereas receptor agonists attenuated inflammation. These results demonstrate a protective role of the endocannabinoid system in contact allergy in the skin and suggest a target for therapeutic intervention.
Similar articles
-
Anti-inflammatory activity of topical THC in DNFB-mediated mouse allergic contact dermatitis independent of CB1 and CB2 receptors.Allergy. 2013 Aug;68(8):994-1000. doi: 10.1111/all.12183. Epub 2013 Jul 29. Allergy. 2013. PMID: 23889474
-
Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.Brain Res Mol Brain Res. 2004 Dec 6;132(1):87-92. doi: 10.1016/j.molbrainres.2004.08.025. Brain Res Mol Brain Res. 2004. PMID: 15548432
-
Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors.Neuropharmacology. 2008 Jan;54(1):141-50. doi: 10.1016/j.neuropharm.2007.07.005. Epub 2007 Jul 19. Neuropharmacology. 2008. PMID: 17709120
-
Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond.Addict Biol. 2008 Jun;13(2):147-59. doi: 10.1111/j.1369-1600.2008.00108.x. Addict Biol. 2008. PMID: 18482430 Review.
-
The endocannabinoid-CB receptor system: Importance for development and in pediatric disease.Neuro Endocrinol Lett. 2004 Feb-Apr;25(1-2):24-30. Neuro Endocrinol Lett. 2004. PMID: 15159678 Review.
Cited by
-
Microbiomic differences at cancer-prone oral mucosa sites with marijuana usage.Sci Rep. 2019 Sep 3;9(1):12697. doi: 10.1038/s41598-019-48768-z. Sci Rep. 2019. PMID: 31481657 Free PMC article. Clinical Trial.
-
Deficiency of CB2 cannabinoid receptor in mice improves insulin sensitivity but increases food intake and obesity with age.Diabetologia. 2010 Dec;53(12):2629-40. doi: 10.1007/s00125-010-1894-6. Epub 2010 Sep 11. Diabetologia. 2010. PMID: 20835701
-
CB1 receptors mediate rimonabant-induced pruritic responses in mice: investigation of locus of action.Psychopharmacology (Berl). 2011 Aug;216(3):323-31. doi: 10.1007/s00213-011-2224-5. Epub 2011 Feb 22. Psychopharmacology (Berl). 2011. PMID: 21340468 Free PMC article.
-
The cannabinoid receptor type 2 (CNR2) gene is associated with hand bone strength phenotypes in an ethnically homogeneous family sample.Hum Genet. 2009 Nov;126(5):629-36. doi: 10.1007/s00439-009-0708-8. Epub 2009 Jun 30. Hum Genet. 2009. PMID: 19565271
-
Cannabinoids in the management of difficult to treat pain.Ther Clin Risk Manag. 2008 Feb;4(1):245-59. doi: 10.2147/tcrm.s1928. Ther Clin Risk Manag. 2008. PMID: 18728714 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases